Group items tagged

Scientists mice with different HIV viruses and then edited the viruses out of their genes using gene editing technology called CRISPR/Cas9. They then used a live bioluminescence imaging system created by one of the researchers (Won-Bin Young, PhD.) to see that they had completely removed the HIV viruses from the genes. They now want to test primates, and then do clinical trials on people.

To date, only nonembryonic human stem cells have been used in cell-based gene therapy studies. The inherent limitations of these stem cells, as discussed below, have prompted scientists to ponder and explore whether human embryonic stem cells might overcome the current barriers to the clinical success of cell-based gene therapies.

AstraZeneca PLC unveiled agreements that should enable the pharmaceutical company to tap into a promising, nascent gene technology aimed at making drugs more precise. AstraZeneca said it hopes the technology will help it accelerate the discovery of new treatments, a process that normally takes years.

In a study published Tuesday, researchers say "cancer drivers" -- altered genes that contribute to the disease's progression -- can be identified through health data exchange. The researchers used an algorithm to analyze integrated data from the Cancer Genome Atlas and the Protein Data Bank. Health IT Interoperability. This is one time using personal data can be used for a great purpose!